Approximately 15–20% of patients with multiple myeloma carry a t(4;14) translocation, which induces NSD2 overexpression from an immunoglobulin heavy chain locus (IGH)-NSD2 hybrid, along with a global increase and redistribution of H3K36me2 in the affected cells8. This evidence concerns the gene NSD2 and AL amyloidosis.